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INTRODUCTION 
 
One billion of world population, all ages and ethnic groups are affected 
by Vitamin D deficiency. Nowadays, Gestational vitamin D deficiency is 
common. High prevalence of vitamin D was seen in developing (such as 
Bangladesh, India, Iran, Pakistan, Somalia) as well as developed countries 
(such as Australia, Finland, Japan, the Netherlands, United Kingdom and 
USA).  
Normal body function is regulated by vitamin D. Vitamin D is a fat 
soluble vitamin.  Vitamin D is naturally present in few foods, produced 
endogenously when exposed to ultraviolet rays. Vitamin D biologically inert 
and must undergo hydroxylation in our body for activation .There are two 
major forms of vitamin D are vitamin D2 (ergocalciferol) and vitamin D3   
(cholecalciferol) (1). Vitamin D is a derivative of cholesterol.  Naturally 
Vitamin D is available in food like fish -Tuna, fish liver oil, egg yolks, cheese 
and mushroom. Fatty flesh fish and fish liver oil is the best source of          
vitamin D.  
Vitamin D is produced in the skin when exposed to ultraviolet light. 
The ultraviolet light acts on 7-dehydrocholesterol producing pre-vitamin D.  
Pre-Vitamin D is then converted to vitamin D, which enters the circulation 
2 
 
which travels to the liver. In the liver, vitamin D is 25-hydroxylated to form 
25-hydroxyvitamin D [25(OH) D] levels of 25(OH) D are measured to assess 
the levels of vitamin D in the body and is a precursor to the active metabolite 
1, 25-dihydroxyvitaminD [l,25(OH)2D]. Exclusively released from the 
kidneys, 1, 25-(0H)2 D plays an important role in calcium homeostasis along 
with parathyroid hormone produced and released from the parathyroid glands. 
The action of 1, 25(OH) 2 D is to increase the absorption of calcium from the 
intestine and inhibit the secretion of parathyroid hormone to maintain a 
normal serum level of calcium level. Vitamin D acts on vitamin D receptors 
that are found in many different tissues in the body, and plays an important 
role in glucose regulation, cardiovascular system, bone mineral density and 
many other biological functions.  
Vitamin D plays a role in glucose metabolism by regulating insulin 
secretion and/or by increasing the sensitivity of tissue to insulin. High blood 
pressure is found in vitamin D deficiency. Low levels of vitamin D were 
associated with low vascular endothelial growth factor (VEGF) and increased 
pro-inflammatory cytokines which can cause damages in the vessel.  It 
increases intestinal absorption of calcium and reduces the secretion of 
parathyroid hormone. This is to maintain serum calcium levels. Low levels of 
vitamin D lead to the release of parathyroid hormone, which takes up calcium 
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out of the bone and decreases bone mineral density which affect the bone 
strength. Normal range of vitamin D facilitates the absorption of calcium 
from intestine, increases the calcium channel and calcium binding protein. 
Vitamin D is needed to maintain various body functions like immunity, 
increases calcium absorption from intestine, decreases PTH synthesis ,decreases 
Left ventricular hypertrophy, improves bone osteoclastic differentiation, 
improves hematopoiesis and increases insulin secretion from Vitamin D 
Deficiency can lead to imbalances in the regulation of many systems. Vitamin 
D deficiency can predispose the individuals to Gestational diabetes mellitus, 
hypertension, cancer, bone development issues in children and many other 
conditions.    Getting adequate vitamin D is important to help maintain normal 
serum calcium levels and homeostasis within the body Vitamin D facilitates 
active absorption of the calcium in the small intestine by increasing the calcium 
channel and increasing the calcium binding protein expression and it interacts 
with vitamin D receptor in osteoblasts and promotes the maturation of 
preosteoclasts.  
 
Vitamin D has a number of extra skeletal functions. Vitamin D binding to 
the vitamin D receptor (VDR) and regulates the hundreds of genes (either 
directly or indirectly) including those that control key processes affecting cell 
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fate. The complexity of vitamin D action is further increased by VD-0gene 
polymorphism. The reported associations with plethora of phenotypes 
(including cancer, autoimmune, cardiovascular, metabolic, and renal and many 
other diseases) have been extensively met analyzed and reviewed. Vitamin D 
also exerts  Reno protective and antiproteinuric effects with several mechanisms 
involved including inhibition of renin-angiotensin aldosterone system (by 
decreasing renin expression), suppression of inflammation (by reducing 
accumulation of inflammatory cells), and restoration of glomerular filtration 
barrier (by attenuating podocyte damage) According to the committee of the 
Institute of Medicine. 
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Table-1: Serum 25-Hydroxyvitamin D [25(OH)D] Concentrations and 
Health 
 Serum 25-Hydroxyvitamin D [25(OH)D] Concentrations and Health* [1] 
nmol/ ng/mL* Health status 
<30 <12 Associated with vitamin D deficiency, leading to rickets in 
infants and children and osteomalacia in adults 
30 to 
<50 
12 to 
<20 
Generally considered inadequate for bone and overall     
health in healthy individuals 
≥50 ≥20 Generally considered adequate for bone and overall health In 
healthy individuals 
>125 >50 Emerging evidence links potential adverse effects to such 
high levels, particularly >150 nmol/L (>60 ng/mL) 
* Serum concentrations of 25(OH) D are reported in both nano moles per liter 
(nmol/L) and nanograms per milliliter (ng/mL). 
** 1 nmol/L = 0.4 ng/ml 
Vitamin D deficiency during pregnancy can have many negative health 
effects for the mother and developing fetus. The fetus gets vitamin D from the 
mother. When the mother has vitamin D deficiency, the fetus is also predisposed 
to vitamin D deficiency in early infancy, which may lead to many health issues 
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in the future including delayed milestones, Rickets etc. Normal level of maternal 
l, 25(OH)2 D which increases gradually from the first trimester to the third 
trimester. The increase in serum level of vitamin D is due to the increase in 
production of 1, 25 (OH)2 D (l). Fetal calcium levels depend on the maternal 
vitamin D level and are normally higher than maternal levels throughout the 
gestation. Calcium is actively transported across the placenta into fetal 
circulation. Fetal vitamin D levels are usually 20% lower than maternal levels.  
Vitamin D crosses the placenta during the last trimester of gestation. This 
develops the fetal vitamin D stores. If the mother has vitamin D deficiency, 
then, less vitamin D will be transported across the placenta and the fetus will 
have a low vitamin D store at birth (6). Low levels of vitamin D at birth may 
predispose the infant to low calcium levels and rickets over the first few months 
of life
.
 This indicates that vitamin D deficiency in the mother can have a direct 
impact on the developing fetus (1). 
 
Lower levels of vitamin D in pregnant women has increased due to 
multiple risk factors such as lack of adequate sun exposure, darker skin 
pigmentation, sunscreen usage , clothing coverage full body and latitude of 
residence and ethnicity. 
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One study has shown that approximately 29 % of Black pregnant women 
and 5% of white pregnant women living in northeastern United States are 
vitamin D deficient (2).  
 
Vitamin D deficiency during pregnancy has been linked. Some of the 
adverse outcomes for the mother are pregnancy induced hypertension, 
preeclampsia, gestational diabetes, and an increased rate of cesarean section 
(four fold increases risk –according to RCOG 2014)  Although it is not clear 
with adequate levels of maternal and neonatal vitamin D, these adverse 
outcomes can be avoided . 
The largest and main source of vitamin D in adults is synthesis from solar 
radiation; half an hour of sunlight delivers 50 000 is of vitamin D with white-
complexioned skin. Dietary intake of vitamin D makes a relatively small 
contribution to overall vitamin D status as there is little vitamin D that occurs 
naturally in the food supply which absorbed through intestine and circulate. 
Melanin absorbs ultraviolet B (UVB) from sunlight and diminishes 
cholecalciferol production by at least 90%. 
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Figure-1: Pathophysiology of Vitamin D 
 
                       
Maternal hypocalcaemia leads to Pre-eclampsia and neonatal 
hypocalcaemia which is the most prevalent complications and associated with 
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morbidity. A statistical association of glucose intolerance and low level of 
vitamin D has been done.  
EFFECT ON FETUS - Maternal low vitamin D leads to certain fetal 
complication which include  
A) Poor lung development and neonatal immune conditions such as asthma,  
B) Small size at birth 
C) Skeletal problems in infancy and childhood and neonatal morbidity 
including Childhood Rickets.  
D) In an Australian study,-. Maternal Vitamin D deficiency is a major cause of 
hypocalcaemia seizures in neonates and infants. Hypocalcaemia is not 
uncommon in neonates and is a potentially severe problem. Mothers of 
babies who suffer hypocalcaemia seizures are more likely to be vitamin D 
deficient (85%) than mothers of babies who do not (50%).In another study 
from Egypt; all mothers of babies with hypocalcaemic seizures had severe 
vitamin D deficiency. Supplementation with vitamin D to pregnant women 
can prevent these complications.  
E) Schizophrenia 
F) Autism 
G) Mental retardation 
H) Three times more likely to develop juvenile diabetes before the age of 15 
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I) Craniotabes is softening of the skull bones that occurs in 1/3 of ―normal‖ 
newborns. Recent evidence indicates it is yet another sign and sequela of 
maternal vitamin D deficiency. 
EFFECT ON MOTHER : 
A) Caesarean section 
B) Preeclampsia 
C) Gestational diabetes 
D) Bacterial vaginitis 
 Marya et al., (72) conducted randomized case control study involving 200 
Asian Indian pregnant women. She randomly grouped. Group 1 100 – they 
received 6 lakhs IU of vitamin D twice during last trimester. Group 2- includes 
100 pregnant women without supplementation. High Serum calcium level and 
Serum Alkaline phosphatase were low in pregnant women who were treated 
with vitamin D and they were compared. Cord blood sample were collected 
between these two groups and compared the values of high Serum calcium level 
and low alkaline phosphatase level in Group 1. Group 1 infant had greater 
intrauterine growth, greater birth weight greater head-toe length, and greater 
head circumference than group 2.  
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 Recent American study (74) published in April 2017 says that 400 IU of 
vitamin D daily per orally had the greatest benefits in preventing preterm birth 
and IUGR and infection. Vitamin D is needed to improve in immune function, 
healthy cell division and healthy bone development in neonates and in mother. 
Vitamin D supplementation in addition to reducing insulin resistance it also 
reduces the preeclampsia. Vitamin D hormone is available in sunlight. Due to 
certain factors the absorption of vitamin D is delayed. 
PREVALENCE OF GESTATIONAL DIABETES 
 The prevalence of Type II Diabetes is increasing globally including India. 
In 1997 WHO   estimates the prevalence of diabetes in adults showed an 
expected total rise of >120% from 135 million in 1995 to 300 million in 2025. 
As of today, we have no current national data regarding the occurrence of 
abnormal glucose tolerance in the pregnant women. Southern Asia is at the top 
of the diabetes projections list with an expected total rise of 79.4 million people 
by 2030. Current national diabetes prevalence is 4.3 % Studies conducted in 
India in the last decade have highlighted that  the prevalence of type 2 diabetes 
high and  also that it is increasing rapidly especially in the urban population 
than rural population. An urban-rural difference in the prevalence rate was 
found, indicating that the environmental factors related to urbanization had 
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significant role in increasing the prevalence of diabetes. Boddula at al (75)., 
reported a prevalence of diabetes of 21.2 % and an Impaired Glucose Tolerance 
rate of 18.2% in an urban south Indian population of high socio-economic group 
with significant difference which is explained  by obesity. 
 Diabetes mellitus is diagnosed in Reproductive age group women more 
frequently. Such reproductive age group women become pregnant with their 
pregnancy complicated by diabetes mellitus and complication associated with 
uncontrolled diabetes. With increasing sedentary life style, lack of physical 
exercise and lack of activities they are increased chance of obesity and 
development of Type II diabetes mellitus at early age. Family history also 
contributes to development of Diabetes Mellitus at earlier. The trend toward late 
marriage and late conception, the epidemic of obesity and diabetes, decrease in 
physical activity, adoption of modern lifestyles, diet high in saturated fat and 
smoking may all contribute to an increase in the prevalence of DM.  
 GDM is associated with severe perinatal complications, offspring of 
GDM mother are at risk of developing DM in life. Besides obesity, another 
major independent risk factor for GDM is vitamin D deficiency is now being 
postulated along with multiple other effects on the mother and the fetus. 
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 The main purpose of this paper is to find out the new emerging issues of 
vitamin D deficiency during pregnancy. Estimation of Vitamin D level in 
normal pregnant women and Gestational diabetes mellitus. Its deficiency has 
effect on both the mother and the developing fetus. This project includes a 
review of the literature regarding vitamin D during pregnancy in India and 
foreign countries. The need for universal screening for pregnant women who are 
at risk of vitamin D deficient and provide them with the necessary 
supplementation is still not recommended. 
Vitamin D and GDM: 
 Gestation diabetes mellitus (GDM) is one of the adverse effects of 
vitamin D deficiency.  Gestational Diabetes Mellitus complicates up to  14% of 
pregnancies depending on ethnicity, diagnostic methods employed and criteria 
used. About 8% of Asian mothers have a pregnancy complicated by gestational 
diabetes. In most of the cases the carbohydrate intolerance reverts after 
pregnancy, itself back but heralds the onset of type 2 diabetes later in life. 
Women diagnosed to be diabetic early on in pregnancy are probably cases of 
pre-gestational diabetes who have become overt due to the stress of pregnancy. 
A woman with random plasma glucose > 200mg/dl with features of polydipsia, 
polyphagia and polyuria with unexplained weight loss or with plasma fasting 
glucose > 126 mg/dl is probably a pregestational diabetes, which was latent 
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during the pre-gestational period and has become overt later in their life. 
Nevertheless, assessment 6 weeks after delivery is necessary and regular follow 
up is needed in their life. 
 
In our hospital, we routinely screen for GDM between 24-28 weeks of 
gestation by ingesting a 75 gram glucose load irrespective of meal and plasma 
blood is drawn and measured and they are classified according to diet controlled 
or medication controlled. In some hospital, it is followed up by a 100gram, 3-
hour glucose tolerance test (GTT). A fasting glucose level is measured followed 
by an hourly glucose measure in the 3-hour GTT for a total of 4 glucose 
readings. If two or more of the four measurements are high in the 3-hour GTT, 
then the patient is diagnosed with GDM (5).  
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Figure 2:Universal screening for all antenatal patient 
 
 
 
Table 2: 100g OGTT diagnostic criteria for gestational diabetes mellitus  
Status 
Carpenter-Coustanplasma or serum 
glucose level 
National Diabetes 
Group plasma level 
  Mg/dl Mg/dl 
Fasting  95 105 
One hour  180 190 
Two hour  155 165 
Three hour  140 145 
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RISK FACTORS FOR GDM  
 
1. l. Previous history of gestational diabetes or glucose intolerance  
2. A family history of diabetes  
3. Previous macrosomia (> 4,000 g)  
4. Previous unexplained stillbirth  
5. Previous neonatal hypoglycemia, hypocalcemia, or Hyperbilirubinemia  
6. Advanced maternal age  
7. Obesity  
8. Repeated glycosuria in pregnancy  
 
Figure:3 showing the risk factor for Vitamin D deficiency 
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Figure 4: Pathophysiology of glucose Metablolism: 
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IMPAIRED GLUCOSE TOLERANCE (IGT) and IMPAIRED  
FASTING GLUCOSE (IFG):  
a) Fasting plasma glucose >= 100mg/dl but <126 mg/dl  
b) 2-hour value in OGTT >= 140mg/dl but <200mg/dl  
The White classification, named after Priscilla White who pioneered 
research on the effect of diabetes on perinatal outcome, is widely used 
to assess maternal and fetal risk. It distinguishes between gestational 
diabetes (type A) and diabetes that existed before pregnancy (pre-
gestational diabetes). These two groups are further subdivided 
according to their associated risks and management. 
 
According to American Diabetes Association 2014  
Criteria for diagnosing Overt diabetes 
  HBA1C > 6.5 % 
 Fasting blood glucose > 126 mg/dl  (no caloric intake for last 8 hours) 
 2 hour  plasma glucose > 200 mg/dl during 75 gm of OGTT ( WHO 
CRITERIA) 
 Random plasma glucose > 200 mg/dl  with symptoms of hyperglycemia.  
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There are 2 classes of gestational diabetes:  
 Class A: gestational diabetes; diet controlled  
 Class A2: gestational diabetes: medication controlled. The second group 
of diabetes, which existed before pregnancy can be split up into these 
classes:  
Table 3: White’s Classification 
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An early age of onset of diabetes or long-standing disease comes with 
greater risks, hence the first three subtypes  
GDM affects about 7% of all pregnancies worldwide and about 2, 00,000 
annually 
(13)
. It has been shown that there are vitamin D receptors on the 
pancreatic beta cells, which produce and secrete insulin. This suggests that 
vitamin D deficiency plays a role in the regulation of insulin secretion. It may 
also affect glucose metabolism by increasing cellular absorption or by 
enhancing the effect of insulin (14). In third trimester, vitamin D synthesis is the 
highest and it is where the presence of insulin resistance is common. The GDM 
levels of vitamin D remain low late into the pregnancy compared to vitamin D 
levels of normal pregnant women (14).  Vitamin D deficiency affects maternal 
health by predisposing women to develop Gestational diabetes mellitus and or 
diabetes mellitus type 2 later in their life.  
 
Type I diabetes (TID) or insulin dependent diabetes is caused by 
autoimmune destruction of pancreatic cells.  The incidence of TID are higher 
were observed especially in higher latitudes worldwide (19, 20). According to 
one study concluded that normal level of vitamin D had 30% reduction in risk 
of developing Type 1 diabetes (21, 22)
. 
Insulin is overproduced  by pancreatic ß 
cells (Type 2 DM), but it is ineffectively utilized by the target cells. As a 
response to hyperglycemia, pancreatic ß cells produce more insulin and leads to 
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hyperinsulinemia, which is often indicative of a pre- stage or Type 2 diabetes 
mellitus. Hyperinsulinemia is associated with increased risk of developing 
hypertension, obesity, dyslipidemia, and glucose intolerance (23). These 
conditions are collectively known as "metabolic X syndrome‖.A meta-analysis 
showed inverse relationship of serum Vitamin D and serum calcium level with 
insulin resistance. In this meta-analysis, supplementation with both the vitamin 
D and calcium showed benefit in optimizing glucose levels (25). 
 
The Third National Health and Nutrition Examination Survey (NHANES 
Ill) did not demonstrate an association between 25(OH) D levels and diabetes or 
insulin resistance in African Americans, in contrast to Caucasians and Mexican 
Americans. In another study of European Caucasian subjects, insulin secretion 
and action were not associated with levels of 25(OH) D. It is vital that such 
studies are controlled for obesity, a risk factor itself for vitamin D deficiency.  
  
Scientific impact paper no.43 from RCOG says that depending on the 
diagnostic criteria they were used, it has been suggested that GDM complicates 
up to 16% of pregnancies (55, 56) although the true incidence can be much 
greater in some ethnic groups. There are some data to suggest that the 
association between vitamin D levels and GDM risk is specific to ethnicity. In a 
majority non-Hispanic white population, vitamin D level  at 16 weeks of 
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gestation were significantly lower in GDM subjects than in controls, whereas no 
association was found in Indian mothers where vitamin D ( 
54,58) concentrations were measured at 30 weeks of gestation. Some studies 
have investigated more than one ethnic group using statistical techniques to 
correct for the effect of ethnicity, but none have been designed to describe the 
association in specific ethnic populations. Conversely, a well conducted study 
has found no association between maternal 25(OH) D and the development of 
GDM in ethnic group. A meta-analysis of 31 studies demonstrated vitamin D 
insufficiency was associated with a higher risk of GDM (59). 
 
Other adverse effects of Vitamin D deficiency in the mother: 
 
Pregnancy induced hypertension (PIH), or gestational hypertension, is 
defined as a systolic blood pressure equal to or above 140 or a diastolic blood 
pressure equal to or above 90 that is recorded on two different occasions with 6 
hours apart  develops after 20 weeks‘ gestation and return to normal value 
within 6 weeks post-delivery , without proteinuria.  According to one theory 
PIH may be caused by an altered metabolism of calcium and parathyroid 
hormone due to vitamin D deficiency (4,74)  Maternal Vitamin D levels 
increase greatly in the third trimester than in early trimester. If pregnant mother 
is vitamin D deficient, there are alterations in calcium absorption and 
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homeostasis. This alteration in calcium absorption, homeostasis mechanisms 
leads to development of hypertension in pregnancy or gestational hypertension.  
 
Another theory suggests that an increased release of cytokines into the 
maternal blood stream causes vessel injury and develop Gestational 
hypertension (16). There are many complications associated with PIH such as 
placental ischemia, the development of preeclampsia and later the development 
of eclampsia (16) and study suggested that may be associated with vitamin D 
deficiency. These adverse effects can greatly increase the morbidity and 
mortality of both the mother and fetus. Placental ischemia causes decreased 
oxygen and nutrients to be delivered to the fetus which can lead to increased 
morbidity and mortality of the fetus.  
 
Preeclampsia (PE) is a serious and life-threatening condition consisting 
of hypertension, proteinuria (protein in the urine) and other clinical findings 
(16). It is a pregnancy specific syndrome that affects 37% of first pregnancies 
(2). Vitamin D deficiency has been implicated in the development of 
Preeclampsia by its effect on controlling blood pressure (4). Other theories 
suggest that increased vascular endothelial growth factor (VEGF) during 
pregnancy leads to PE. VEGF causes vascular damage and dysfunction, which 
leads to an increase in the blood pressure which predisposes the mother to 
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develop PE
 
(16). Vitamin D insufficiency (vitamin D levels between 37.5 — 
80 nmol/L) is an independent risk factor for developing preeclampsia. PE 
affects maternal health by increasing her risk for developing eclampsia and 
other life threatening complications associated with it (16). If eclampsia 
develops fetus is also at risk (16).  
 
Mothers who are vitamin D deficient are at increased risk of having a 
caesarian section. As of 2009, the current U.S birth rate by C-section is 30.2% 
compared to 5% . Several factors can increase the risk of C-section, including 
muscle weakness associated with vitamin D deficiency, GDM, and PE, which 
leads to placental ischemia. Women who are vitamin D deficient at the time of 
delivery are 4 times more likely to deliver by C-section. One theory suggests 
that skeletal muscle also have vitamin D receptors with muscle weakness as 
well as suboptimal muscle performance and strength during labor and delivery 
is associated with vitamin D deficiency. GDM causes the fetus to be larger in 
size, making it harder to deliver vaginally. If the large fetus is delivered 
vaginally, there is a higher risk of injury or the fetus can suffer from asphyxia 
(12). Placental ischemia leads to intrauterine fetal growth restriction and 
reduced birth weight, which are associated with increased morbidity and 
mortality to the fetus. In order to save the fetus and reduce the risk of morbidity 
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and mortality, the fetus is delivered by C-section and is usually delivered 
prematurely (16). 
 
Vitamin D deficiency is associated with many conditions that greatly 
affect maternal health. Not only ones‘ deficiency affects the mother during 
pregnancy, but it also affects her health in the future. Long term vitamin D 
deficiency increases the mother's risk of developing diabetes mellitus type 2, 
osteoporosis and cancer. Vitamin D plays an important role in insulin 
regulation, bone mineralization and the development of cancer  
Figure:5 Vitamin D deficiency and adverse outcome: 
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Neonatal effects of vitamin D deficiency:  
Deficiency not only affects maternal health during pregnancy but it also 
affects neonatal health. The fetus develops its vitamin D store from the mother 
in the third trimester. If the mother is deficient, then the fetus will not develop a 
sufficient vitamin store6. The lack of sufficient vitamin D store predisposes the 
neonate to increased morbidity and mortality. Some of the issues the neonate 
faces are bone mineralization issues, which can lead to the development of 
rickets, and small for gestational age (1)
. 
There is a wide range of morbidity that 
can be seen with vitamin deficiency in the neonate. This includes issues with 
brain development, heart failure/cardiomyopathy, asthma and type I diabetes. 
 
GDM which is caused by vitamin D deficiency increases the likelihood of 
morbidity in the fetus by causing the fetus to be large for its gestational age, 
also known as macrosomia (12). Macrosomia is caused by glucose being 
transferred across the placenta rather than insulin. Glucose is the primary 
substrate used for fetal growth. With increased levels of glucose, the fetal 
growth rate is expected to increase, leading to the overgrowth of the fetus (13). 
Macrosomia is associated with birth related injuries such as Erb's palsy and 
asphyxia. Erb's palsy is caused when the fetus is in a breech position and is 
delivered arm first. Pulling of the arm to deliver the fetus leads to damage to the 
brachial nerve plexus that is located in the shoulder region (12). 
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Infant bone mass is influenced by maternal vitamin D levels. The neonate 
is born with an insufficient store of vitamin D due to maternal deficiency and 
breast milk is a poor source of vitamin D3 the neonate has no way of getting 
vitamin D unless they are supplemented with it. Vitamin D plays an important 
role in bone mineralization through altering maintains calcium homeostasis. 
This occurs when calcium levels are too low. When vitamin D levels are low, 
parathyroid hormone is released which stimulates the kidney to convert 25(OH) 
D to 25(OH) 2 D which increases calcium absorption. Infants who are deficient 
have increased levels of parathyroid hormone and are hypocalcemia, which 
affects bone mineral density and can lead to rickets. Infants who are vitamin D 
deficient are more likely to have lower bone mineral densities as well as bone 
deformities that can be seen in-utero. Severe vitamin D deficiency during 
gestation or early infancy is the primary cause of rickets. Rickets is 
characterized by enlargement of the epiphyses of the long bones, deformities of 
the legs, growth retardation, bending of the spine, knobby projections from the 
ribcage and weak and toneless muscles which is also accompanied by seizures 
in young infants. This leads to long term morbidity due to the bone deformities.  
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Maternal deficiency has been correlated with low birth weight, length and 
growth in the first year of the neonate's life. Being born with a low birth weight 
and length may increase the risk of morbidity and mortality simply because they 
are small for gestational age. Low levels of vitamin D have been associated with 
low levels of insulin like growth factor (IGF-I), an important hormone in fetal 
growth in maternal and umbilical cord blood which may lead to neonates being 
born small for gestational age 10. Also, placental ischemia caused by PE causes 
growth retardation causing the baby to be small for gestational age16, Being 
small for gestational age increases morbidity and mortality for the neonate. If 
the baby is born at term, they are less likely to have complications associated 
with their size. If the infant is born prematurely, their organs are not fully 
developed and are at risk of suffering from morbidity and mortality. 
 
One of the morbidities a neonate can experience from maternal vitamin D 
deficiency during development is the long-term effect on the brain. It is 
suggested that vitamin D plays a role in the development of the central nervous 
system8. The brain is able to synthesize its own active form of vitamin D and 
expresses its own vitamin D receptors, which are widely expressed in the 
cortex, cerebellum, mesopontine area, diencephalon, spinal cord, amygdala, and 
hypothalamus. Vitamin D deficiency during development leads toincreased 
cellular proliferation in the brain and reduced apoptotic cell death which can 
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result in long-term or even permanent damage in the brain8. Deficiency during 
development could be linked to the increased incidence in neurological 
disorders such as schizophrenia. The incidence of schizophrenia is higher in 
people living in higher latitudes and in individuals with darker skin. There is a 
higher incidence of schizophrenia in African Americans and other darker 
skinned people, since over 40% of African American women of child bearing 
age are vitamin D deficient. In some populations of females that have high skin 
pigmentation and low sun exposure, the prevalence of vitamin D deficiency can 
be as high as 80%, further increasing the risk of the developing fetus developing 
permanent or long term brain damage (8). 
 
Another serious morbidity a neonate can develop is heart failure due to 
dilated cardiomyopathy. Dilated cardiomyopathy is a heart condition in which 
the left ventricle is dilated leading to a decrease in muscle strength and the 
amount of blood that can be pumped out with each beat. This causes blood to 
remain in the ventricle after the 9 ventricles contract which leads to an increased 
and systolic volume. Heart failure occurs due to the low cardiac output which 
results in hypotension, poor perfusion, breathlessness and even death. Vitamin 
D plays a key role in calcium balance, which is important for heartcontractility. 
Vitamin D deficient humans have type IL muscle fiber atrophy as well as 
increased interfibrillar spaces and fat infiltration, which leads to muscle 
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weakness.  Also, vitamin D deficiency leads to hypocalcemia and an increased 
level of parathyroid hormone. Parathyroid hormone stimulates the release of 
calcium from the bones to increase the serum calcium level to correct 
the hypocalcemia. Hypocalcemia alone is sufficient to cause dilated 
cardiomyopathy and eventually heart failure (9). This condition can be treated 
with any drugs and calcium alone, but improvement is slow.  
Vitamin D is also linked to the increased incidence of asthma in children 
of deficient mothers. The lungs epithelial cells express a high baseline lug- 
hydroxylase, which is an important enzyme that converts inactive 25(OH) to 1, 
25 (OH) 2 D, the active form of vitamin D915). 
 
The active form of vitamin D 
acts on the vitamin D receptors (VDR) in the lungs and plays a role in down-
regulating airway remodeling, pro-inflammatory modulator release and 
bronchial smooth muscle proliferation (15). This suggests that lower vitamin D 
levels could lead to bronchial smooth muscle proliferation, pro-inflammatory 
modulator release, and airway remodeling. This leads to a hypersensitive airway 
and remodeling due to the inflammation and activation of metalloproteinase 
which play an important role in remodeling of the lungs. Vitamin D also 
interacts with several immune cells such as T-cells, monocytes, macrophages 
and mast cells (15). Mast cells play an important role in the inflammatory and 
allergic response associated with asthma. Mast cells are found in higher number 
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in an asthmatic lung than in a healthy lung. It has been demonstrated that 
vitamin D increases apoptosis and inhibits maturation of mast cell precursor 
cells in the bone marrow (15). Adequate Vitamin D leads to aless sensitive 
airway and decreases remodeling caused by asthma.  
 
Fiigure -6: Vitamin D deficiency in Indian population:  
  
Classification of Vitamin D deficiency:  
 The serum concentration of 25(OH) D is the most reliable marker 0f 
vitamin D. In the publications, investigators reported their data on 25(OH) D 
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levels either as nmol (nanomoles per liter) or ng/ml. To simplify information 
and for the ease of comparison, in this review all the data on 25(OH) D levels 
were presented in a single concentration unit for serum 25(OH) D levels-ng/ml. 
Most investigators had used different cutoff levels to define vitamin D  as 
deficiency, insufficiency and normal levels. While some may have done so due 
to preference, other investigators defined their own cut-off levels as determined 
by the linear regression between 25(OH) D levels and PTH levels.  
 
Serum Vitamin D estimation:  
 Plasma 25(OH) D or calcidiol (a summation of and forms) is the most 
reliable marker of vitamin D status. For estimation of vitamin D  various 
Immunoassays such as radioimmunoassay (RIA), enzyme 
linked immunosorbent assay (ELISA),  chemiluminescence immunoassay and 
protein binding assays are used in routine testing of 25(OH) D in clinical 
laboratories. LCTMS (liquid chromatography tandem mass spectrometry) is the 
widely accepted reference method for 25 (OH) D measurements. However, 
LCTMS is difficult to perform , very expensive and time consuming and 
therefore seldom used commercially. 
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Vitamin D and sun exposure in India:  
 In India, Vitamin D deficiency is a major health concern not withstanding 
the brightly shining sun. The "adequacy of exposure to sunlight of an 
individual's bare skin" required to photosynthesize vitamin D is grossly ill 
understood. Darker skin  have high melanin which acts as a natural sunscreen. 
Thus, darker skin produces a significantly lesser amount of vitamin D when 
compared with the individuals with fairer skin Thus, for Indian skin tone, 
minimum "direct sun exposure" required daily is more than 45 min to bare face, 
arms and legs to sun's UV rays (wavelength 290—310 nm). Due to changing 
life style pattern sun exposure is not adequate. Indian social and or religious 
norms related to public modesty dictate that most parts of an individual's body, 
irrespective of gender, be covered by clothes. They perforce to live in 
overcrowded tenements, and closely packed.  
 
Nutritional factors attributing to high prevalence of Vitamin Deficiency in 
India:  
 Vitamin D sufficiency by dietary intake is the only solution for Indians. 
However, this solution itself has many problems.  
 Most dietary sources of vitamin D have very low vitamin D content.  
Animal sources are rich in vitamin D. Most Indians are vegetarians. 
Commonly, a diet rich in  vitamin D are  milk and milk products , 
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provided milk and milk products  has been fortified with vitamin D. But 
in India it is rarely fortified with vitamin D. The vitamin D content of 
unfortified milk is very low (2 IU/IOO mL). Due to low socioeconomic 
status it is  unaffordable to buy milk and milk products in India . Another 
concern in India is the rampant dilution and/or adulteration of milk and 
milk products. 
 
 Low calcium in Indian diet: Dietary intake of low level of calcium along 
with low level of Vitamin D is associated with secondary 
hyperparathyroidism (SHPT). SHPT is further exacerbated by destruction 
of 25(OH) D and 1, 25(OH) 2D by 24hydroxylase (32). 24 
hydroxylasesis the key enzyme of vitamin D catabolism and is regulated 
by 1, 25(OH) 2D, PTH and FGF 23 (Fibroblast Growth Factor 23) levels. 
FGF 23 is a phosphate regulator. High level of serum phosphate increases 
the production of FGF 23 in bone osteocytes via the action of 1, 25(OH) 
2D. Subsequently, FGF 23 reduces renal phosphate resorption, indirectly 
suppresses intestinal phosphate absorption and also suppresses PTH 
and synthesis. Overproduction of FGF 23 can result in increased 
morbidity which is associated with vitamin D deficiency. This regulatory 
mechanism may explain the low 25(OH) D levels in rural subjects on a 
high phytate and/or low calcium diet, despite plentiful sun exposure. 
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Most studies reported calcium intake much lower than the RDA 
(Recommended Daily Allowance) defined by the Indian Council of 
Medical Research (ICMR). Only two studies reported adequate calcium 
intake. In both these publications the study subjects were paramilitary 
soldiers (26, 27).In India calcium intake is lower than that of the western 
world according to  ICMR's - RDA.  
 
 Our body is to maintain calcium balance depending on intake and 
excretion (34, 35). Even though the Indian diet which  is low in calcium 
content, lower protein content and therefore low endogenous acid 
production, which may reduce urinary calcium loss. Therefore, the 
amount of diet rich in calcium is required to maintain calcium balance 
may be lower than for those in the Occident. The protein-induced 
alterations in calcium homeostasis (and possibly in bone mass) have been 
attributed to increases the  production of endogenous acid and net acid 
excretion due to the oxidation of the constituent Sulphur containing 
amino acids. On the other hand, in India the high salt content diet is likely 
to increase urinary calcium excretion. A direct relation between the high 
sodium intake and lower bone mass had been reported (36). 
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 In India, due to very high intake of caffeine from various sources 
including coffee. They consume milk which is a part of their tea or 
coffee. The quantity of milk is very low in these drinks. The level of   
calcium intake through these beverages is very low. During cooking 
Vitamin D is stable even up to 200 0C. However, thermal stability of 
vitamin D during cooking and the duration of cooking is an inverse 
function. In India, milk is boiled for several minutes and several times 
before consumption. In India most of the times, beverages including tea 
and coffee are boiled for several minutes at different temperature to get 
the right flavor. Repeated boiling of milk may reduce the level of vitamin 
D . Therefore, these beverages may not contribute significantly to either 
calcium or vitamin D intake in Indians. Vitamin D is a fairly robust 
vitamin. The preceding statements about its thermal degradation had been 
made as precautionary stance to not overstate the thermal robustness of 
this micronutrient. Additionally, studies had been reported regarding the 
association of high caffeine intake with increased risk of developing  low 
bone mineral density, osteoporosis, and osteoporotic fractures in middle-
aged women. This situation is exacerbated in women with low calcium 
intake, especially in lean subjects (37) when compared to obese women. 
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 In India high prevalence of lactose intolerance is a major deterrent 
pertaining milk consumption, further lowering intake of calcium and 
vitamin D in these individuals. Ethnic and geographic variations of 
people with intolerant to lactose  were observed, with a higher prevalence 
in southern (Dravidian descent) and eastern India compared to northern 
India (Aryan descent). 
 
 Indian diet has high phytate content. Phytate is the principal storage form 
of phosphorus in many plant tissues, especially in  the bran portion of 
grains and other seeds. Phytate is not digestible to human intestine. 
Micronutrients such as calcium and iron absorption from intestine is 
reduced due to phytate . Benefits of sun exposure in rural subjects owing 
to an agrarian life were seen and there is  significantly higher 25(OH) D 
levels (42) were found . However, due to consumption of diet which is 
rich in phytate there is insufficient level of these micronutrients in most 
individuals. Possibly, high phytate content in the diet of soldiers in 
northern India may have contributed to their vitamin D insufficiency or 
deficiency, despite adequate exposure to sun light, nutrition and physical 
exercise (27). 
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 In India Consumption of diet rich in Phytate especially among the socio-
economically lower classes stems from the elementary and immediate 
need of sufficiency of the calorific need. Cereals and legumes are more 
affordable and easily available than vegetables, milk and other dairy 
products. Besides, they are sources of protein for the vegetarians. Many 
cereals are also sources of calcium, however due to chelation by phytates 
its bioavailability is limited. 
 Notably, nearly all studies pertaining vitamin D status in healthy subjects 
reported a high level of  phytate/ calcium intake ratio. What Indians may 
require is a higher intake of calcium diet to lower the phytate/calcium 
intake ratio. Dietary habits in India have been changing significantly. 
Many people remove a substantial proportion of bran from whole wheat 
flour before kneading to improve texture and fluffiness of chapattis 
(unleavened flat bread) and also to increase the taste of the food. 
Consumption of white bread is also very high. Most people prefer 
processed, split and polished pulses to whole seeds due to the ease of 
shorter time required for cooking and the consequent lowered expense of 
cooking fuel. Consumption of junk foods including burger / instant (or 
not) noodles/pizza also is on the rise across all socio-economic strata, 
with exception. 
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 In the scenario of inadequate calcium intake, vitamin D insufficiency and 
high phytate content in diet, environmental pollutants such as fluoride 
add insult to injury. Toxins like fluoride  affect bone metabolism severely 
in the conjunction with inadequate calcium intake and low level of serum 
vitamin D , especially in children (43,44). 
 
 Cooking practices in India: Indians in general adhere to traditional 
cooking styles and practices, irrespective of their migration to different 
part of the world. In tropical climate, perishable food items putrefy 
quickly. Consumption of uncooked fresh produce, especially vegetables, 
milk, etc., is generally considered ill-advised. As in the rest of the world, 
in India too, slow cooking is widely practiced and cooking at varying 
temperature and stability of vitamin D  . Pertaining shallow and deep-
frying of food, most cooking fats and oils have smoke points above 180 
oc. Shallow and deep frying of foods is very popular in India. When 
foods are fried, vitamin D in the food comes out into the cooking medium 
and is thermally degraded (46). Pressure cooking temperatures vary 
depending on the pressure withstood by the cooker used and may range 
from 100 oc to 120 oc. Short-time (as short as possible) pressure cooking 
is definitely advisable to retain at least some of the thermally more stable 
essential nutrients in cooked food, including vitamin D. 
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 Publications indicating wide prevalence of vitamin D deficiency in 
healthy Indians have studied subjects mostly from lower and upper 
middle classes. Individuals below poverty line were not represented well 
in these studies. Hence, poor nutrition observed in these studies may also 
stem from lack of awareness of the features, benefits and necessity of 
balanced nutrition. 
 
Screening for vitamin D deficiency in pregnancy  
There are no data to support routine screening for vitamin D deficiency in   
pregnancy.  There is an argument that some groups of women who are pregnant 
should have a screening test: for example, on the basis of skin color or 
coverage, obesity, risk of pre-eclampsia or gastroenterological conditions 
limiting fat absorption. As the test is expensive, offering it to all at-risk women 
may not be cost effective compared to offering universal supplementation, 
particularly as treatment is regarded as being very safe. At present, there are no 
data to support a strategy of measurement followed by treatment in the general 
female population (60). Measurement of vitamin D in a hypokalemic pregnant 
women or symptomatic woman includes women with a low calcium 
concentration, bone pain, gastrointestinal disease, alcohol abuse, a previous 
child with rickets and those receiving drugs which reduce vitamin D.  
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Supplementation and treatment in pregnancy  
Daily vitamin D supplementation with oral cholecalciferol or 
ergocalciferol is safe in pregnancy. The 2012 recommendation from UK Chief 
Medical Officers and NICE guidance state that all pregnant and breastfeeding 
women should be informed about the importance of vitamin D and should take 
10 micrograms of vitamin D supplements daily (61,62).Particular care should 
be taken over high-risk women. The recommendations are based on the classical 
actions of vitamin D, although many of the non classical actions of vitamin D 
may be beneficial. As mentioned above, the review and meta-analysis 
by Aghajafari et al. found associations between vitamin D insufficiency and risk 
of gestational diabetes, pre-eclampsia, bacterial vaginosis and SGA infants". Of 
course, this does not necessarily demonstrate that correction during pregnancy 
will reduce these risks.  
 
Three categories of vitamin D supplementation are recommended (RCOG- 
2014).  
1. In general, vitamin D 10 micrograms (400 units) per day is 
recommended for all pregnant women in accord with the national  
guidance (61).This should be available through the Healthy Start 
programme(63)  
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2. High-risk women are advised to take at least 1000 units per day (women 
with increased skin pigmentation, reduced exposure to sunlight, or those 
who are socially excluded or obese) (64).  Women at high risk of pre-
eclampsia are advised to take at least 800 units per day + combined with 
calcium. Vitamin D may be inappropriate in sarcoidosis (where there may 
be vitamin D sensitivity) or ineffective in renal disease. Deficient renal I-
u hydroxylation necessitates the use of active vitamin D metabolites, such 
as luhydroxycholecalciferol or 1, 25-dihydroxycholecalciferol. Specialist 
medical advice should be sought in such cases. The limitation to therapy 
compliance mostly relates to the calcium which has a side effect of 
tasting of chalk, rather than the vitamin D element of oral therapy. It is 
often more appropriate to give vitamin D alone for patient acceptability. 
However, this is limited by the availability of suitable agents; vitamin D 
cannot be prescribed at low doses without calcium. 800-unit formulations 
of cholecalciferol without calcium are available (e.g. Fultium-
D3, Internis, London; Desunin, Meda, Bishop's Stortford, UK). There 
may be particular benefits of vitamin D/calcium supplementation in 
women at risk of Pre-eclampsia (66, 67). 
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3.  Treatment for the majority of women who are deficient in vitamin D, 
treatment for 4—6 weeks, either with cholecalciferol 20 000 IU a week or 
ergocalciferol 10,000 IU  twice a week, followed by standard 
supplementation, is appropriate (68,69). For women who require short-
term repletion, 20,000 IU weekly appears to be an effective and safe 
treatment of vitamin D deficiency. A daily dose is likely to be appropriate 
to maintain subsequent repletion (1000 IU daily). In adults, very high 
doses of vitamin D (3, 00,000—5, 00,000 IU intramuscular [1M] bolus) 
may be associated with an increased risk of fractures and such high doses 
are not recommended in pregnancy. A 2011 study demonstrated that 
supplemental doses of 4000 IU cholecalciferol a day were safe in 
pregnant women and most effective compared to the lower doses (70). 
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Table4: Supplementation and treatment recommendation (RCOG – 2014) 
 
Supplementation Daily units Combined with 
Vitamin D 400 (a) 
800 (b) 
1000 (c) 
Not applicable 
Calcium 
Not applicable 
 Treatment 
Cholecalciferol 
Ergocalciferol  
 
2800 
2800(d) 
 
20,000IU once a wk 
10,000 IU twice a wk 
 
 
a. Recommended for all pregnant women  
b. Recommended for women with high risk of pre-eclampsia  
c. Recommended for women at high risk of vitamin D deficiency  
d. To be taken through and after the high-dose supplementation 
 
Vitamin D supplementation and fortification in India:  
 Supplements commonly available are-D3 (cholecalciferol), and 1 alpha 
hydroxy vitamin D3 (alfacalcidol). Some formulations have calcium too. 
Multivitamin formulations are also available and contain about 400 IU of D3. 
D3 supplement of 60,000 IU is the highest selling one and is available in 
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powder form in sachets or as oil-based capsules. Recommended dose on the 
label is once per week. The sachets indicate that half a sachet per week may also 
be taken. According to some pharmacists, many clinicians recommended one 
sachet daily for 10 days, followed by one sachet/week for 5—6 weeks to 1 
sachet/week forever. The other vitamin D supplements mentioned here are 
present in lower doses (0.25 pg or 500 IU) and daily intake (1-4 times/day) may 
be recommended by the clinicians. Calcium supplementation is generally 
recommended with vitamin D intake. The cost of a single dose of 60,000 IU of 
vitamin is about INR 30. Vitamin D sufficiency via sun exposure is untenable 
for most Indians, as discussed earlier. Vitamin D (relatively) rich dietary 
sources are unaffordable and mostly limited, especially for vegetarians. Most 
Indians are vegetarians. Vitamin D supplements are unaffordable and not 
feasible as a population based approach. Fortification of widely consumed 
staple foods with vitamin D is the only viable solution towards attaining vitamin 
D deficiency in India (17). Unlike supplementation strategies, fortification of 
food with vitamin D poses a negligible risk of toxicity.  
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AIM AND OBJECTIVES 
AIM:  
The objective of this study is to determine the impact of vitamin D 
deficiency on maternal complications like Gestational Diabetes Mellitus 
(GDM). 
OBJECTIVES:  
Primary Objectives: Assessing the levels of vitamin D in pregnant women. 
 To study the vitamin D status of pregnant women with GDM complicating   
pregnancy after 37 weeks (GROUP –A). 
 To study the normal vitamin D levels in pregnant women without any 
complication after 37 weeks (GROUP- B). 
Secondary Objectives: Correlation between vitamin D levels and Gestational 
diabetes mellitus in pregnant women. 
The justification for this study: Low levels of vitamin D status, as measured 
by 25-hydroxyvitamin D [25(OH) D], are common in pregnant women. There is 
a positive association between vitamin D status and adverse pregnancy 
outcomes like Gestational Diabetes Mellitus.  
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MATERIALS AND METHODS 
Source of Data:  
The study will be conducted on all low risk antenatal and GDM patients 
admitted in the PSG IMSR – Labour Ward, Coimbatore. 
Study design: Prospective longitudinal observational study. 
Study Population: 
 All low risk antenatal mothers as control group and Gestational diabetes 
mother as study group admitted in PSG institute of medical sciences and 
research, Coimbatore – labour ward after 37 weeks of gestation between August 
2016 to August 2017. 
Study Locale (geographic area): Department of obstetrics and Gynaecology- 
Labour ward  PSG Institute of Medical science and research centre, peelamedu , 
Coimbatore.  
Sample Size: With reference -Vitamin D status and gestational diabetes 
mellitus according to Jayaraman Muthukrishnan, Goel Dhruv 
DOI: 10.4103/2230-8210.163175 
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FORMULA 
N =2x(2alpha +2 beta)2 x SD2 
(M t – m c)2 
SD= 28, 
Mt= 24.7 
Mc  = 45.8 
2alpha +2 beta = 7.84 
N  = 2x7.84 x28 x28 
  (24.7 -45.8 )2 
 = 12293 
 445.21 
Result = 27 in each group.  
So approximately taking 30 in each group. 
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Sampling Method:  
 All low risk pregnant mothers visiting labour ward will be selected 
randomly as control group (Group-B) and Gestational diabetes mother as study 
group(Group -A). Patients will be randomly allocated to either one of the 2 
groups. 
Duration of study: 1 year (August 2016- 2017) 
Inclusion Criteria: 
 All low risk  pregnancy 
 Vertex and non vertex presentation. 
 Age < 35 yrs 
 Pregnancy complication (GDM) – on Diet  
 Gestational age after 37 weeks  
Exclusion Criteria: 
 Overt diabetes. 
 Abnormal placental presentation 
 Other complications (PIH, anemia, preeclampsia, multiple gestation) 
 Other medical complications ( chronic kidney disease) 
 GDM  on insulin and OHA 
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 Gestational age < 37 weeks  
 Not willing for study. 
 On steroids, Metformin. 
Data collection and proforma will be done only by the PI 
Methodology  
 30 pregnant women with GDM were selected randomly and classified 
as GROUP A. 30 low risk pregnant women with normal blood glucose 
levels were selected randomly and classified as Group B. 
 All low risk pregnant women between 24-28 weeks of gestation were 
screened for GDM by an Oral Glucose tolerance test with 75 gm of  
glucose in 200 ml of water irrespective of meal.  
 3 ml of venous blood sample were collected after 2 hours.  
 3ml blood will be collected after getting consent form and sent to 
biochemistry department for Vitamin D level estimation method is 
ELECROCHEMILUMINESCENCE IMMUNOASSAY (ECLIA).The 
obtained results will be compared between low risk antenatal patients 
and Gestational Diabetes Mellitus patients. 
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REVIEW OF LITERATURE 
 
Robert J et el., Vitamin D deficiency in pregnant women leads to low 
level of vitamin D in unborn fetus and the complications associated with it. 
 
One study was published in PLOS One by Grass roots health – conducted 
in South Carolina-  1000 pregnant women - 25-hydroxyvitamin D  serum level 
of greater than or equal to 40 ng/ml had 60% reduction in preterm birth   which 
is significant p=0.0001. 
 
Madhu Jain et el., conducted study in NORTH INDIA- deficiency of 
Vitamin D as a risk factor for Gestational Diabetes Mellitus- Maternal deficiency 
of Vitamin D in early pregnancy is highly prevalent and it is an independent risk 
factor for Gestational diabetes mellitus. Supplementation of Vitamin D to 
pregnant women would prevent or improve in glycemic control needs further 
clinical trails. 
Heather H Burris et al.,(78)  In this study Sixty-eight (5.2%) women 
met criteria for GDM. Unadjusted analysis revealed that women with vitamin D 
levels <25 vs. ≥25 nmol/L analyzed and had significantly increased odds ratio 
for GDM (OR 3.6, 95% CI 1.7, 7.8. Adjustment analysis for race/ethnicity, age, 
education status, marital status, smoking, parity and season of blood draw made 
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little difference to this estimate (OR 3.1, 95% CI 1.3, 7.4). Additional 
adjustment analysis for maternal BMI attenuated the association and the 
confidence interval included the null value (OR 2.2, 95% CI 0.9, 5.6). Further 
adjustment for pregnancy weight gain made little difference (OR 2.3, 95% CI 
0.9, 5.7). Addition of physical activity and dietary intakes of fish and calcium 
also made little difference (OR 2.2, 95% CI 0.8, 5.5). 
Study conducted in ARMED forces in Pune by Jayaramam 
Muthukrishnan et al., (53) Study concluded that level of Vitamin D is 
associated with GDM. Low level of Vitamin D was associated with GDM. 
However replacement of Vitamin D does not reverse the glucose intolerance. 
There is no justification or standard guidelines  at present for routine screening 
for Vitamin D deficiency in all antenatal pregnant women. 
Heather H. Burris et al., (71) conducted another publication, regarding 
maternal serum level of vitamin D in second trimester in Gestational diabetes 
mellitus. Low levels of maternal serum Vitamin D is inversely proportional to 
the risk of GDM.  OGTT were done and levels were compared. 
Pittsburg Public Health study conducted by Alison Gernard et al. used a 
random sample of 2,146 pregnant women who participated in the Collaborative 
Perinatal Project, which was conducted in 12 U.S. medical centers from 1959 to 
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1965. If pregnant mother was deficient before 14 weeks, her baby had twice the 
risk of developing intrauterine growth restriction in utero. 
Hannah Furfaro et al., study was conducted in Netherland and 
published in June 2017. They have included 4,000 children for this study. At the 
age of 6, only 68 children had Autism. Researches said statistically significant 
link between the low levels of vitamin D in pregnant women and children with 
Autism. No one knows the exact mechanism for developing Autism. In this 
study they recommend low dose of Vitamin D daily till delivery. 
Marya et al., (72) conducted randomized case control study involving 
200 Asian Indian pregnant women. She randomly grouped. Group 1 100 – they 
received 6 lakhs IU of vitamin D twice during last trimester. Group 2- includes 
100 pregnant women without supplementation. High Serum calcium level and 
Serum Alkaline phosphatase were low in pregnant women who were treated 
with vitamin D and they were compared. Cord blood sample were collected 
between these two groups and compared the values of high Serum calcium level 
and low alkaline phosphatase level in Group 1. Group 1 infant had greater 
intrauterine growth, greater birth weight greater head-toe length, and greater 
head circumference than group 2.  
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Veronica Boyle et al., (73) - significant number of pregnant women do 
not meet the recommended levels. Neonates whose mother lad significant low 
level of vitamin D during her pregnancy had  had a thinning of bone at birth and 
greater risk of developing rickets later in life. Beyond calcium homeostasis the 
consequences of vitamin D not yet clearly understood. Vitamin D plays a role in 
other system including inflammation, vascular function and glucose 
metabolism, renal.    
Recent American study published in April 2017  Carol L.Wagner  et al., 
(74) says that 400 IU of vitamin D daily per orally had the greatest benefits in 
preventing preterm birth and IUGR and infection. Vitamin D is needed to 
improve in immune function, healthy cell division and healthy bone 
development in neonates and in mother. Vitamin D supplementation in addition 
to reducing insulin resistance it also reduces the preeclampsia. Vitamin D 
hormone is available in  sunlight ,in order for the body to manufacture it 
properly. Due to certain factors the absorption of vitamin D is delayed. 
Jain M et al., Maternal Vitamin D  Deficiency: done in North India  A 
Risk Factor for Gestational Diabetes Mellitus in North India-  case control study 
was done taking 550 random antenatal women. Two maternal blood samples, 
one at <20 wks and the other at term along with cord blood were taken. Study 
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concluded that maternal vitamin D deficiency is highly prevalent in early 
pregnancy and is an independent risk factor for GDM in North India (52). 
Anna PleskaIova et al (76)., confirmed in her article that  overall high 
prevalence of vitamin D deficiency in pregnant women in spite of the GDM 
presence. The  most striking observations of  this study are significantly higher 
prevalence of early postpartum 25(OH)D deficiency in women with GDM 
history compared to those without. Potentially beneficial effect of vitamin D 
supplementation and the pathogenic role of vitamin D deficiency in the 
subsequent development of type 2 diabetes mellitus in women  with GDM 
history has to be further explored considering the role of vitamin D in 
modulating insulin sensitivity and glucose metabolism. 
See Ling Loy et al., (84) published an article ―Association of maternal 
D status with glucose tolerance and LSCS  in an multi ethnic Asian cohort: 
the growing up in Singapore towards healthy outcome (GUSTO) study‖  
they have measured vitamin D level and 2 hour Post prandial glucose level were 
measured between 26-28 weeks of gestation. They defined Vitamin D as 
inadequacy and adequacy i.e. <75nmol/l (<30ng/ml) and >75nmol/l (>30ng/ml) 
respectively. Mode of delivery was obtained from hospital records. They have 
940 pregnant women from Singapore. They concluded vitamin D inadequacy is 
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prevalent in pregnant women, particular among the Malay and Indian. This is 
associated with elevated fasting blood glucose level in Malay women , and 
increased risk of emergency LSCS  among Chinese  and Indian  women. 
Bejat Sasan et al.,(85) ―The Effects of Vitamin D Supplement on 
Prevention of Recurrence of Preeclampsia in Pregnant Women with a History of 
Preeclampsia.‖ They presented a  study which is a randomized controlled 
clinical trial. Aim of the study is to  determine the effect of vitamin D 
supplement on reducing the probability of recurrent preeclampsia. 72 patients 
were placed in control group while 70 patients were randomized to the case  
group. The case  group received a 50000  IU pearl vitamin D3 once every two 
weeks. The control group was administered placebo. Vitamin D or placebo was 
given until the 36th week of pregnancy. They have concluded that Vitamin D 
supplementation therapy in pregnancy could help in reducing the incidence of 
gestational hypertension/preeclampsia. 
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OBSERVATION AND RESULTS 
 
The mean age of study group is presented in Table 5. It is observed that, 
the mean age of my case group is 27.53 + 3.69 years.  The mean age of my 
control group is 26.67 + 3.177 years.  Majority of my patients fall between 21-
30 years. 
 
Table - 5: Age distribution 
Age Cases % Control % 
< 20 0  2 6.6% 
21  - 25 9 30% 7 23.3% 
26 - 30 16 53.3% 17 56.6% 
31 - 35 4 13% 4 13.5% 
> 35 1 3.3% 0  
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Table - 6: Occupation  
Occupation Case % Control % 
House wife 24 80% 26 86.7% 
Professional 6 20% 4 13.3% 
 
Table 6 shows that majority of the patients fall under house wife 
category. Professional category includes staff nurses, IT professionals and 
Teachers. 
 
Figure- 7:  Occupation with study group 
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Table -7:  Education status 
 
Education Cases % Control % 
School Level 14 46.6% 13 43.3% 
Graduates 16 53.4% 17 56.7% 
 
 Majority of the patients, almost 58 % were graduates in my groups. 
 
Figure -8:  Education status 
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Table-8: Body Mass Index  
 
BMI Cases % Control % 
18.5 - 24.9 14 46.7% 16 53.4% 
25.0 - 30.0 12 40% 13 43.3% 
> 30.0 4 13.3% 1 3.3% 
 
             BMI distribution shows that, in my case group, around 13% of the 
women had BMI higher than 30 kg/m
2 
(obese), while 40% had BMI  between 
25 and 30 kg/m
2
(overweight) and 46 % had BMI below 25 kg/m
2
(normal).  In 
my control group, around 3 % of the women had BMI higher than 30 kg/m
2 
(obese), while 43% had BMI between 25 and 30 kg/m
2 
(overweight) and 53% 
had BMI below 25 kg/m
2 
(normal). It is inferred that the Chi-square test of 
association is insignificant (p>0.05) between these groups. 
 
 
 
 
 
61 
 
Table- 9 BMI distribution 
 
  
SD 
95% CI for Mean 
Minimum Maximum sig 
BMI Mean Lower Upper 
Cases 25.5 4.8 23.7 27.3 18.5 34.3 
 
Control 24.4 3.9 22.9 25.8 18.5 30.0 >0.05 
 
Mean BMI of my case group is 25.5+ 4.8 and for the control group is 
24.4 + 3.9.  
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Table- 10:  Gestational age  
 
GA Cases % Control % 
37 - 38 13 43.3% 7 23.3% 
38 - 39 8 26.7% 8 26.7% 
39 - 40 9 30% 15 50% 
 
 
Table- 11: Comparison of gestational age with Vitamin D level 
 
Study 
Vitamin D 
Total < 20 > 20 
 
 
CASE 
GA 37 - 38 
12 2 14 
38 - 39 
8 2 10 
39 - 40 
4 2 6 
 
 
CONTROL 
GA 37 - 38 1 2 3 
38 - 39 5 2 7 
39 - 40 14 6 20 
 
 
       Gestational age at the time of evaluation was compared between the two 
groups. Women with gestational age between 37 to 40 weeks were included in 
my study. From the table 11- it is observed that, 46% and 10 % of women 
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presented in labour ward between 37 – 38 weeks of gestational age in case and 
control group respectively.  Around 20 % of case group and 66% of control 
group were presented in labour ward between 39- 40 weeks of gestational age. 
Patient in case group tend to present in early term than control group but it is 
not statistically significant. 
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Table- 12:  Duration of sun exposure  
Duration Cases (%) Control (%) 
0 - 3 hrs 11 37% 6 20% 
4 - 8 hrs 19 63% 23 77% 
8 - 12 hrs 0 
 
1 3% 
> 12 hrs 0 
 
0 
                   
                          
Table -13: Mean exposure to sunlight 
Study 
 SD 
95% CI for 
Mean 
Minimum Maximum sig Groups Mean Lower Upper 
CASES 4.1 1.7 3.4 4.7 1 7 
 CONTROLS 4.4 1.6 3.8 5.0 1 9 >0.05 
         
The duration of Sun exposure and mean exposure to sun light is presented 
in Tables 12 and 13. Majority of women had poor exposure to sun due to 
changing life style and occupation. Mean exposure to sun in case and control 
group is 4.1 + 1.7 hours and 4.4 + 1.6 hours respectively. In Indian population, 
the exposure of face, arms and legs in sunlight for 2 hours is needed for dark 
skinned people, but for fair skinned people, only 30 minutes is needed daily. 
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Table – 14: Chief complaints and safe confinement  
 
Chief Complaints Cases % Control % 
Labour Pain 9 30% 10 33.3% 
PROM 11 36.7% 9 30% 
Induced labour 10 33.3% 11 36.7% 
 
Table –14 :  shows the time of presentation to the labour ward and were 
categorized.  Percentages between these two groups were similar.  
 
Table- 15: OGTT -2 hr  
 
Mg/dl Cases (%) Control (%) 
< 120 0 0 29 96.7% 
120 - 140 8 26.7% 1 3.3% 
> 140 22 73.3% 0 
   
Table 15 shows that 73.3% of women in study group had elevated levels 
of OGTT  and  96.7% of women in control group were within the normal range 
. 
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Table -16: Mean OGTT - 2 hours 
 
 
Study 
Groups 
 SD 
95% CI for 
Mean Minimum Maximum sig 
Mean Lower Upper 
CASES 147.0 9.0 143.7 150.4 130 160 
 
CONTROLS 98.6 11.6 94.3 103.0 74 128 <0.001 
 
 
OGTT levels were compared between the case and control group.  Mean 
OGTT of my case group is 147 + 9.  Mean OGTT of the control group is 98.6 + 
11.6. The ‗P‘ value is significant (i.e.) < 0.001. Vitamin D level is inversely 
proportional to OGTT. 
Figure - 9:  Correlation of OGTT with Vitamin D (study group) 
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Figure -10: Correlation of OGTT with Vitamin D (control group) 
 
 
 
  In Figure 9 and 10 - correlation of vitamin D with OGTT level were 
compared. Women with low levels of vitamin D have elevated OGTT levels.  
Hence Vitamin D is inversely proportional to OGTT.  
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Table-17: Comparison of vitamin D status 
 
 
Cases % Control % 
Deficiency 
(0-20ng/ml) 24 80% 21 70% 
Insufficiency 
(21-30 ng/ml) 4 13.3% 7 23.3% 
Normal 
(>30 ng/ml) 2 6.7% 2 6.7% 
 
Table- 18: Mean Vitamin D level 
Mean Vitamin D with study Groups 
Study 
Groups 
Mean SD 
Std. 
Error 
95% CI 
for Mean 
Maximum 
Lower 
CASE 14.59 7.35451 1.34274 11.8438 34.44 
CONTROL 15.9667 7.79572 1.4233 13.0557 32.48 
 
Of the 60 antenatal women included in the study, only 6.7% of women 
were found to have normal vitamin D levels, all others having either 
insufficiency 18.3% or deficiency 75 %. In India, there is a very high 
prevalence of low levels of vitamin D among pregnant women in spite of our 
country being tropical. This may be attributed to  diets low in vitamin D , dark 
pigmented skin , social and religious norms related to public modesty dictating 
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that most of the  body must be covered (lack of sun exposure). Mean exposure 
to sun in case group is 4.1 + 1.7 and control group is 4.4 + 1.6. 
 
 The Vitamin D status is analyzed in table 17 and 18.  It is observed that, 
in case group, around 80% of women had vitamin D deficiency, whereas it is 
only 70% in control group. In case group around 13.3% of women had vitamin 
D insufficiency whereas it is 23.3% in control group. In both case and control 
groups, around 6.7% of women were within the normal range. Mean vitamin D 
is 14.5 + 7.3 in case group and 15.96 + 7.7 in control group. By comparing the 
Vitamin D  deficiency between the 2 groups by Chi-square test, the levels were 
found to be statistically insignificant. 
 
Figure - 11: Comparison of vitamin D status 
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Table -19: Association of Mode of Delivery with Vitamin D levels  
  CASE CONTROL 
Vitamin D NVD (%) LSCS (%) NVD (%) LSCS (%) 
Deficient 20 66.7% 4 13.3% 17 56.7% 4 13.3% 
Insufficient 4 13.3% 0 0% 4 13.3% 2 6.7% 
Normal 2 6.7% 0 0% 3 10% 0 0% 
 
Table  19  shows the  mode of delivery between two groups. It is 
observed that, 56.7% of control group had normal vaginal delivery. In case 
group 66.7% had normal vaginal delivery. In deficiency, 13.3% of case and 
control group underwent LSCS. 
 
Table-20: Duration of labour 
Duration Cases (%) Control (%) 
<12Hrs 5 17% 15 50% 
12 - 16 Hrs 8 27% 4 13% 
17 - 24 hrs 14 47% 9 30% 
>24 hrs 4 13% 2 7% 
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Table-21: Mean Duration of labour 
Study    
SD 
95% CI for 
Mean 
Minimum Maximum sig Groups Mean Lower  Upper  
CASES 17.5 7.0 14.5 20.6 4 29 
<0.05 
CONTROLS 
14.1 6.7 11.4 16.8 3 28 
 
The relationship between the duration of labour and Vitamin D status is 
analyzed by Pearson correlation coefficient. The obtained p value of <0.05 is 
significant.  It is inferred that the duration of labour is prolonged with low level 
of vitamin D. The mean duration of labour among case group is 17.5+ 7 hours 
and among control group is 14.1+ 6 hours. 
Figure -12:  Duration of labour 
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Table -22: Neonatal birth weights 
Baby Weight [kgs] Cases % Control % 
<2.5 5 16.6% 1 3.3% 
2.51 - 3.0 14 46.6% 19 63% 
3.01 - 3.5 11 36.7% 8 26.7% 
>3.5 0  2 6.6% 
Total 30  30 
  
The mean birth weight of babies between these two groups is 2.51 – 3 kg. 
The Pearson correlation shows insignificant relationship (p>0.05) for birth 
weight. Therefore the Vitamin D levels of antenatal women does not 
significantly influence the birth weight.  
Table- 23: Mean neonatal birth weight between groups 
 
Study  
Mean SD 
95% CI for 
Mean 
Minimum Maximum sig Groups Lower Upper 
CASES 2.8 0.3 2.7 3.0 2.2 3.5   
>0.05 
  CONTROLS 2.9 0.3 2.8 3.0 2.3 3.6 
 
              It is observed from table 23:  that, the mean birth weight of babies for 
case group is 2.8 + 0.3 kg whereas the mean birth weight of babies in control 
group is 2.9 + 0.3 kg. The Pearson correlation shows insignificant relationship 
(p>0.05) for birth weight. 
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Figure- 14: correlation of vitamin D vs birth weight (case group) 
 
 
 
Figure- 15: correlation of vitamin D vs birth weight (control group) 
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Table- 24: Comparison of case and control 
CLINICAL VARIABLES CASES CONTROL 
Age 
Mean+/-SD 27.5+/-3.7 26.7+/-3.2 
Occupation 
House Wife 32% 35% 
Professional 8% 5% 
Education 
School Level 47% 43% 
Graduation 53% 57% 
BMI 
Mean+/-SD 25.5+/-4.8 24.4+/-3.9 
Chief Complaints 
Abdominal Pain 30% 33% 
PROM 37% 30% 
Induced 33% 37% 
GA 
37 - 38 43% 23% 
38 - 39 27% 27% 
39 - 40 30% 50% 
Exposure of sun light 
Mean+/-SD 4.1+/-1.7 4.4+/-1.6 
GCT 
Mean+/-SD 147+/-9 98.6+/-11.6 
Vitamin D 
Mean+/-SD 14.59+/-7.35 15.97+/-7.80 
Duration of labour 
Mean+/-SD 17.52+/-7 14.1+/-6.7 
Birth Weight 
Mean+/-SD 2.8+/-0.3 2.9+/-0.3 
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STATISTICAL ANALYSIS: 
 
 The data is reported as the mean +/- SD or the median, depending on their 
distribution. 
 The differences in quantitative variables between groups were assessed 
by means of the unpaired T test. Comparison between groups was made 
by the Non parametric Mann - Whitney test. 
 The Chi-square test was used assess differences in categorical variables 
between groups. 
 Correlation was used to assess the variables. 
 A p value of <0.05 using a two-tailed test is considered significant for all 
statistical tests. All data was analyzed with a statistical software package. 
(SPSS, version 16.0 for windows) 
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DATA ANALYSIS 
 
The present work aims to find out whether VITAMIN ‗D‘ is an 
independent risk factor for GDM. A total of 60 antenatal women were enrolled 
in my study. They were randomly allocated into two groups. The antenatal 
women in group A are those with Gestational Diabetes Mellitus and the 
antenatal women in group B  are those without GDM. The association of 
Vitamin D status with reference to age, occupation, education status, Body 
Mass Index, mode of delivery, chief complaints, exposure to sun light, mean 
GCT between these two groups, Mode of delivery, duration of labour and birth 
weight. The data are reported as the mean +/-SD or the median, depending on 
their distribution. The difference in quantitative variable between the groups 
was assessed by means of the unpaired test. Comparison was made between 
these two groups by the non-parametric MANN- Whitney ‗U‘ test. The chi 
square test was used to assess the difference in categorical variables between 
these two groups. P values of < 0.05 using a two tailed test is considered 
significant for all statistical tests. All data was analyzed with a statistical 
software package of social sciences (SPSS- Version 16.0 for windows) 
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DISCUSSION 
 The Study was conducted in the Department of Obstetrics and 
Gynaecology- PSG IMS &R. It was conducted on pregnant women with 
Gestational Diabetes Mellitus on diabetic diet as my study group and on term 
low risk antenatal patients as my control. A sample size of 60 was taken-30 
cases in control group and 30 cases in study group. Additional blood samples (2 
ml) were collected in antenatal patients who were admitted in labour ward 
between 37 weeks and 40 weeks gestation, along with other blood samples. 
 
 The study was analyzed for age, parity, BMI and gestational age (37 to 40 
weeks). They were divided into three groups according to the serum vitamin D 
levels: group 1 (0–20)ng/ml (deficiency), group 2 (21–30)ng/ml (insufficiency), 
and group 3 (more than 30  ng/ml) normal 
 
The mean age of my case group is 27.53 + 3.69 years and control group is 
26.67 + 3.177 years. 
          Majority of patients fell under house wife category.  
         Majority of patients, almost 58 % were graduates. 
BMI distribution shows that, in case group, around 13 % of the women 
had BMI  higher than 30 kg/m
2 
(obese), while 40% had BMI between 25 and 
30 kg/m
2 
(overweight) and 46 % had BMI below 25 kg/m
2 
(normal). In control 
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group, around 3 % of the women had BMI higher than 30 kg/m
2 
(obese), while 
43% had BMI between 25 and 30 kg/m
2 
(overweight) and 53% had BMI below 
25 kg/m
2 
(normal) in control group. Mean BMI of the case group is 25.5+ 4.8 
and for the control group is 24.4 + 3.9. It is inferred that Chi-square test of 
association is statistically insignificant (p>0.05) between these groups. 
 
Gestational age at the time of evaluation was compared between the two 
groups. Women with gestational age between 37 to 40 weeks were included in 
my study. From the table 11- it is observed that, 46% and 10 % of women 
presented in labour ward between 37 – 38 weeks of gestational age in case and 
control groups respectively.  Around 20 % of case group and 66% of control 
group were presented in labour ward between 39- 40 weeks of gestational age. 
Patient in case group tend to present in early term than control group but it is 
not statistically significant. 
 
The association of Sun exposure and Vitamin D status is presented in 
Table 13 -both groups were compared. Majority of women had poor exposure to 
sun due to changing lifestyle and occupation. Mean exposure to sun in case and 
control group is 4.1 + 1.7 and 4.4 + 1.6 respectively. For Indian population, 
exposure of face, arms and legs for 2 hours is needed for dark skinned people, 
but for fair skinned people, only 30 minutes is needed daily. 
79 
 
 Vitamin D level and OGTT levels were compared between the case and 
control group.  Mean OGTT of my case group is 147 +  9.  Mean OGTT of the 
control group is 98.6 + 11.6.  The ‗P‘ value is significant (i.e.) < 0.001. Hence, 
Vitamin D level is inversely proportional to OGTT. 
 
Of the 60 antenatal women included in the study, only 6.7% of women 
were found to have normal vitamin D levels, all others having either 
insufficiency 18.3% or deficiency 75 %. In India there is a very high prevalence 
of low level of vitamin D among pregnant women in spite of our country being 
tropical. This may be attributed to  diet low in vitamin D , dark pigmented skin , 
social and religious norms related to public modesty dictating that most of the 
body must be covered (lack of sun exposure). Mean exposure to sun in case 
group is 4.1 + 1.7 and control group is 4.4 + 1.6. 
 
 The Vitamin D status is analyzed in table 17 and 18:  It is observed that, 
in case group around 80% of women had vitamin D deficiency, whereas it is 
only 70% in control group. In case group around 13.3% of women had vitamin 
D insufficiency whereas it is 23.3% in control group. In case and control group 
around 6.7% of women were within the normal range. Mean vitamin D is 14.5 + 
7.3 in case group and 15.96 + 7.7 in control group. By comparing the Vitamin D 
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deficiency between the 2 groups by Chi-square test, the levels were found to be 
statistically insignificant. 
 
The study conducted in Armed Forces in Pune by Jayaramam 
Muthukrishnan et al., (53) in India concluded that low levels of Vitamin D is 
associated with GDM. However replacement of Vitamin D does not reverse the 
glucose intolerance. There are no justifications or standard guidelines at present 
for routine screening of Vitamin D levels in all antenatal pregnant women.  
 
A study ―Deficiency of Vitamin D among Females of Northern India‖ 
published by RekhaJalandra et al., on pregnant mothers in India, revealed that 
74% of the mothers had vitamin D deficiency (25OHD < 30ng/ml) . Low intake 
of vitamin D by mother in pregnancy is associated with wheeze and asthma in 
the offspring.  Vitamin D deficiency has also been noted in pregnant women in 
tropical countries, but all studies were in Muslim populations, in whom the 
practice of purdah might have played an important role. Vitamin D deficient 
pregnant female may suffer from hypertension, low glucose tolerance whereas 
low birth weight and other complications may be found in new born. Studies on 
pregnant mothers from southern and northern states of India have reported high 
vitamin D deficiency levels with values ranging from 67% to 96%. A study 
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conducted among pregnant mothers in India, reported that 74% of the mothers 
had vitamin D deficiency (< 30ng/ml).  
 
Vitamin D levels are compared with mode of delivery. Table  19:  
showed  mode of delivery between two groups. It is observed that, 56.7% of 
control group had normal vaginal delivery. In case group 66.7% had normal 
vaginal delivery. In deficiency, 13.3% of case and control group were 
underwent LSCS. 
 
See Ling Loy et al., published an article ―Association of maternal 
Vitamin D status with glucose tolerance and LSCS  in the multi-ethnic Asian 
cohort - Growing up in Singapore towards a healthy outcome‖ (GUSTO) study  
the vitamin D levels and 2 hour Post prandial glucose levels were measured 
between 26- 28 weeks of gestation. They classified Vitamin D levels as 
inadequacy and adequacy i.e. <75nmol/l (<30ng/ml) and >75nmol/l (>30ng/ml)  
respectively. Mode of delivery was obtained from hospital records. They had 
940 pregnant women from Singapore. They concluded vitamin D inadequacy is 
prevalent in pregnant women, particular among the Malay and Indian. This is 
associated with elevated fasting blood glucose level in Malay women, and 
increased risk of emergency LSCS among Chinese and Indian women. 
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The relationship between duration of labour and Vitamin D status is 
analyzed by Pearson correlation coefficient. The obtained p of <0.05 is 
significant.  It is inferred that duration of labour is prolonged with low level of 
vitamin D. The mean duration of labour among case group is 17.5+ 7 hours and 
among control group is 14.1+ 6 hours. 
 
The mean birth weight of babies between these two groups is 2.51 – 3 kg. 
The Pearson correlation shows insignificant relationship (p>0.05) for birth 
weight. Therefore a Vitamin D level of antenatal women is not significantly 
influencing the birth weight. 
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SUMMARY 
 Vitamin D levels were compared between GDM patients and normal patients. 
 Women with GDM associated with Vitamin D deficiency tend to present at an 
earlier gestational age for delivery with complaints of abdominal pain/PROM 
than normal patients. 
 In both groups vitamin D level is deficient due to changing lifestyle. 
 Women with low vitamin D levels had prolonged duration of labour when 
compared to low risk women which is statistically significant. 
 There is insignificant association observed between Body Mass Index and 
Vitamin D status. 
 The association of antenatal maternal vitamin D status with birth weight of 
 neonate yields insignificant relationship. 
 The comparison of vitamin D levels between GDM and low risk antenatal 
patients showed statistically insignificant results. 
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CONCLUSION 
  Based on the study conducted in the department of Obstetrics and 
Gynaecology, PSG IMSR, there are many women who are deficient in Vitamin 
D and many others who are insufficient. Prevalence of Vitamin D deficiency is 
alarmingly high in pregnant women in India and has become a re-emerging 
public health issue. Due to lack of Vitamin D level screening, many women go 
undetected and are suffering from adverse outcomes including in new born. So 
there is a need to identify them early in pregnancy and supplementing pregnant 
women with vitamin D and to decrease the likelihood of them developing 
complications. There are some limitations that should be noted. The sample size 
taken was small and hence a large randomized controlled trial is necessary to 
determine the vitamin D levels in pregnancy and to draw guidelines regarding 
screening and supplementation.      
 
I would like to conclude this study saying that in a country like India 
where the prevalence of vitamin D deficiency among pregnant women is high, 
adequate sun exposure, dietary intake and supplementation is necessary. Only 
viable option is fortification of food products and supplementation of vitamin D 
to population at risk. Policies and recommendations should be drawn up by the 
Government of India to combat the pandemic that‘s rising silently. 
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This study shows that overall the vitamin D levels were low in both 
groups. In the study group, mothers went into labour at an earlier gestational 
age and had prolonged labour. However in the control group the gestational age 
was advanced and labour was shortened. Vitamin D levels were slightly higher 
in control group. However this was not statistically insignificant. 
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§¿¡Â¡Ç¢¸ÙìÌ «Ç¢ì¸ôÀÎõ §º¨Å¸¨Ç ¿£í¸û ¦¾¡¼÷óÐ ¦ÀÈÄ¡õ. þó¾ ¬öÅ¢ø Àí§¸ü¸  
´ôÒì¦¸¡ûÙÅ¾¡ø §ÅÚ ±ó¾ Å¢¾Á¡É ÜÎ¾Ä¡É ÀÄÛõ ¯í¸ÙìÌì ¸¢¨¼ì¸¡Ð. ¿£í¸û 
«Ç¢ìÌõ ¾¸Åø¸û þÃ¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ. ¬öÅ¢ø Àí§¸üÀÅ÷¸û ÀüÈ¢§Â¡ «Å÷¸û 
ÌÎõÀò¨¾ô ÀüÈ¢§Â¡ ±ó¾ò ¾¸ÅÖõ ±ì¸¡Ã½õ ¦¸¡ñÎõ ¦ÅÇ¢Â¢¼ôÀ¼¡Ð ±ýÚ 
¯Ú¾¢ÂÇ¢ì¸¢§È¡õ. ¿£í¸û «Ç¢ìÌõ ¾¸Åø¸û / þÃò¾ Á¡¾¢Ã¢¸û / ¾¢Í Á¡¾¢Ã¢¸û «í¸£¸Ã¢ì¸ôÀð¼ 
¬öÅ¢üÌ ÁðÎ§Á ÀÂýÀÎò¾ôÀÎõ. þó¾ ¬ö× ¿¨¼¦ÀÚõ ¸¡Äò¾¢ø ÌÈ¢ôÀ¢¼ò¾Ìó¾ Ò¾¢Â 
¸ñÎÀ¢ÊôÒ¸û «øÄÐ Àì¸ Å¢¨Ç×¸û ²Ðõ ²üÀð¼¡ø ¯í¸ÙìÌò ¦¾Ã¢Å¢ì¸ôÀÎõ. þ¾É¡ø 
¬öÅ¢ø ¦¾¡¼÷óÐ ÀíÌ ¦ÀÚÅÐ ÀüÈ¢Â ¯í¸û ¿¢¨ÄôÀ¡ð¨¼ ¿£í¸û ¦¾Ã¢Å¢ì¸ ²ÐÅ¡Ìõ. 
 
¬ö×ìÌðÀÎÀÅÃ¢ý ´ôÒ¾ø: þó¾ ¬ö¨Åô ÀüÈ¢Â §ÁüÜÈ¢Â ¾¸Åø¸¨Ç ¿¡ý ÀÊòÐ «È¢óÐ 
¦¸¡ñ§¼ý / ¬öÅ¡Ç÷ ÀÊì¸ì §¸ðÎò ¦¾Ã¢óÐ ¦¸¡ñ§¼ý. ¬öÅ¢¨Éô ÀüÈ¢ ¿ýÈ¡¸ô ÒÃ¢óÐ 
¦¸¡ñÎ þó¾ ¬öÅ¢ø ÀíÌ ¦ÀÈ ´ôÒì¦¸¡û¸¢§Èý. þó¾ ¬öÅ¢ø Àí§¸üÀ¾ü¸¡É ±ÉÐ 
´ôÒ¾¨Ä ¸£§Æ ¨¸¦Â¡ôÀÁ¢ðÎ . ¨¸ §Ã¨¸ À¾¢òÐ ¿¡ý ¦¾Ã¢Å¢òÐì ¦¸¡û¸¢§Èý. 
 
Àí§¸üÀ¡ÇÃ¢ý ¦ÀÂ÷, Ó¸ÅÃ¢: 
 
Àí§¸üÀ¡ÇÃ¢ý ¨¸¦Â¡ôÀõ / ¨¸ §Ã¨¸ / ºð¼ôâ÷Å À¢Ã¾¢¿¢¾¢Â¢ý ¨¸¦Â¡ôÀõ: 
 
§¾¾¢ : 
  
¬öÅ¡ÇÃ¢ý ¨¸¦Â¡ôÀõ : 
§¾¾¢  : 
 
¬öÅ¡ÇÃ¢ý ¦¾¡¨Ä§Àº¢ ±ñ: 9566506312 
ÁÉ¢¾ ¦¿È¢Ó¨Èì ÌØ «ÖÅÄ¸ò¾¢ý ¦¾¡¨Ä§Àº¢ ±ñ:  
«ÖÅÄ¸ §¿Ãò¾¢ø0422 2570170 Extn.: 5808 
 «ÖÅÄì §¿Ãò¾¢üÌôÀ¢ý: 9865943043 
  
PROFORMA 
Name   :  
Age   : 
S. No   : 
Op. No  : 
IP. No.   : 
Occupation  : 
Exposure to sunlight : __________________ duration / day 
Address  : 
 
Unit No.  : 
Parity Index  : 
Gestational Age : 
Socia-Economical status : 
Menstrual H/o   : 
Obstetric H/o   : GCT- 
Other antenatal complication in present pregnancy (PIH, Anemia, thyroid dysfunction) 
 
Liquor  : 
Family H/o : 
Medical H/o : 
 
Drug H/o :  Supplementation (Calcium, Vitamin-D) 
Duration and Dosage: 
Investigation :  Vitamin-D level 
Total weight gain : 1
st
 Trimester  2
nd
 Trimester  3
rd
 Trimester 
  
On Examination: 
Vitals       
BP  :   Pallor  : 
Pulse Rate :   Icteric  : 
Temp  :   Pedal Edema : 
Height:_________Cms Weight: ________Kgs  BMI :______________
   
Cardio Vascular System : 
Respiratory System  : 
Per Abdomen  : 
 
Presentation  : 
Fetal Heart Rate : 
Mode of Delivery : 
Indication  : 
Baby Details  : 
 Sex  : 
 Weight : 
 APGAR : 
  
ABBREVATIONS 
T1D   -  Type 1 Diabetes Mellitus 
T2D  -  Type 2 Diabetes Mellitus 
GDM  -  Gestational Diabetes Mellitus 
IGT  -  Impaired Glucose tolerance 
IFG  - Impaired fasting tolerance 
VDR  -  Vitamin D receptor  
PIH  -  Pregnancy Induced Hypertension 
IR  -  Insulin Resistance 
SGA  -  Small for gestational age 
RDA  - Recommended daily Allowance 
ICMR -  Indian council of medical sciences 
WHO  -  World Health Organisation 
NHANES -  National health and nutrition examination survey 
IGR  -  Insulin Like growth factor 
PTH  -  Parathyroid hormone 
 
 
Patient name Age IP NO occupation education BMI chief complaints gestational age exposure to sun GCT controlled sugars vitamin D Duration of labour NVD INSTRUMENTAL LSCS INDICATION FOR LSCS BABY WEIGHT
sowmiya 22 I17022716 HW B COM 20.3 PROM 38W +2D 4 138 DIET 10.7 9 VACCUM 2.93
Sarama 24 I17022947 HW 12TH 20 induced 40W 6 142 DIET 15.99 12 NVD 3.04
Sophia 27 I17023072 HW 10TH 18.5 induced 40W 2 142 DIET 11.52 5 VACCUM 2.52
Indhumathi 22 I17021839 HW 12TH 29.9 abdominal pains 38W +2D 4 144 DIET 9.5 17 forceps 2.3
Hemalatha 28 I17023784 HW 12TH 19.6 induced 40 5 160 DIET 12.7 20 nvd 2.4
Reena 32 I17023806 teacher B.ed 27.1 induced 39 6 130 DIET 13.5 27 nvd 2.7
Poongodi 36 I17024036 HW 10TH 31.7 PROM 37 2 138 DIET 16.02 21 NVD 3.1
Fathima 26 I17024200 HW 11TH 25.7 abdominal pain 38 4 152 DIET 4.26 LSCS NPL 2.9
Sharmila banu 28 I17024342 HW 12TH 28.4 induced 40 5 132 DIET 5.05 22 NVD 2.85
Priya 27 I17024705 Staff nurse B.SC 21.2 prom 38 3 135 DIET 8.46 28 NVD 2.81
Bhuvaneshwari 31 I17024642 IT IT 23.5 induced 39+4D 5 139 DIET 4.85 29 VACCUM 3.1
Yasodha 29 I17025010 teacher B.ed 29.3 prom 37 4 146 DIET 11.54 15 NVD 2.6
Gowri 28 I17025788 HW M.Tech 23.5 induced 40 2 143 DIET 20.16 NVD 3.3
Alagiriammal 30 I17024948 HW 12TH 32.5 induced 38 6 154 DIET 17.4 17 NVD 3
Rajeshwari 28 I17025131 HW IT 34.3 induced 39 2 141 DIET 19.76 LSCS CPD 3.05
Swathy 24 I17025767 HW IT 27.6 prom 38 7 134 DIET 31.15 4 VACCUM 3.08
Amsaveni 35 I17029469 HW 12TH 22.8 abdominal pain 37W+4D 3 154 DIET 22.54 23 NVD 2.2
Revathi 25 I17029537 HW 10TH 29.9 abdominal pain 37W3D 5 146 DIET 6.24 NVD 2.6
Vishnupriya 24 I17029540 HW B.com 28.6 prom 37W+3D 2 150 DIET 12.39 13 NVD 2.4
Rifana 22 I17032108 HW 8th 26.9 prom 39+2 1 148 DIET 5.8 VACCUM 2.68
Priyadharshini 28 I17031211 HW M.Tech 21.8 prom 39 2 148 DIET 19.69 NVD 2.4
Parimala 29 I17032301 HW BBM 19.9 abdominal pain 38+6 5 140 DIET 13.14 17 NVD 3.1
Divya 25 I17032626 HW BBM 29.8 abdominal pain 38+2 7 155 DIET 13.91 15 NVD 2.63
Rameshwari 26 I17032693 HW 11th 19.1 prom 38 4 156 Diet 16.3 17 LSCS CPD 2.74
Radhika 28 I17032584 IT IT 20.6 abdominal pains 39 2 154 Diet 8.83 28 NVD 3.3
Megala 30 I17032585 teacher B.ed 18.9 abdominal pains 38 3 160 DIET 20.66 13 VACCUM 2.89
Sudharani 32 I17033184 HW BIO TECH 22.6 induced 40 6 160 DIET 11.4 19 VACCUM 2.68
Priya 30 I17048143 HW 10 th 29.4 prom 39+2 6 158 DIET 14.56 LSCS NPL 3.5
Parveen fathima 21 I17033275 HW B.A 29.5 abdominal pains 37+1 5 152 DIET 34.44 22 NVD 3.01
Jothi 29 I17033730 HW BBM 32.2 Prom 38 4 160 DIET 25.1 10 NVD 3.5
Patient name Age IP NO occupation education BMI chief complaints gestational age exposure to sun GCT controlled sugars vitamin D Duration of labour NVD INSTRUMENTAL LSCS INDICATION FOR LSCS BABY WEIGHT
Mary 26 I17022674 HW BBM 20.3 prom 38 4 91 18.7 21 VACCUM 3.1
Balavathy 25 I17022267 HW 12th 20 abdominal pain 38+4 5 103 27.4 24 NVD 2.8
Jaishree 27 I17023048 HW B.E 18.5 induced 40 4 128 10.3 18 VACCUM 3.1
Deepika 26 I17023160 HW 12 22.1 prom 37 4 98 16.5 NVD 3.6
Gokilavani 25 I17023966 HW B.A 21.5 induced 40 5 113 10.7 LSCS Fetal distress 2.6
Prema 26 i17024030 HW B.COM 21.8 induced 40+2 5 74 26.4 3 NVD 2.8
Vasudha 29 I17023707 HW 12TH 27 induced 40+2 6 100 14.05 4 FORCEPS 3.15
Deepa 30 I17024572 HW BBM 28.2 abdominal pain 38+3 2 87 5.3 13 VACCUM 2.6
Soundharya 31 I17024663 HW 12 28.5 prom 38+4 5 83 14.4 LSCS Fetal distress 2.56
Shymala 29 I17024662 HW HW 28.2 induced 40 3 86 9.27 LSCS NPL 3.24
Malathy 31 I17024936 LAB tech Lab tech 18.9 induced 40+1 6 103 13.4 12 VACCUM 3.2
Fowzia 25 I17025172 HW 12TH 25.8 abdominal pain 38+3 5 102 20.2 16 VACCUM 3.6
Vidhya 27 I17025228 HW 12TH 26.1 prom 37+4 6 98 8.2 18 VACCUM 2.3
Angel 32 I17025305 HW B.B.M 24.8 induced 40+1 1 93 29.4 16 NVD 2.77
Valli 31 I17025249 HW 9TH 29.5 induced 40+1 4 86 14.22 6 NVD 3.5
Ananthavalli 28 I17024772 HW 10TH 27.6 abdominal pain 38 5 100 14.5 18 NVD 2.6
Geetha 29 I17029522 HW B.COM 22.8 induced 40+1 6 101 20.8 10 LSCS NPL 2.7
Surya 25 I17029524 HW B.TECH 29.9 prom 37 3 89 7.72 17 NVD 2.6
Kowsalya 19 I17030163 HW 10TH 18.7 abdominal pain 39 5 104 15.49 11 VACCUM 3.2
Thasleema 19 I17030604 I.T I.T 19.3 abdominal pain 38+4 4 86 6.13 15 NVD 2.51
Kalaiyarasi 28 I17030609 HW B.TECH 28.01 prom 39+1 4 105 7.8 18 NVD 2.98
Govindammal 22 I17031875 Farmer 4TH 30 prom 38+3 9 100 32.4 19 NVD 3.2
Sugandhi 29 I17031693 HW B.COM 18.5 induced 40+1 1 104 16.18 19 NVD 2.66
Anbarasi 27 I17031126 TEACHER B.ED 22.2 abdominal pain 39+6 3 118 32.48 10 FORCEPS 2.8
Nithya 26 I17029662 HW 12TH 24.6 prom 37 4 85 20.9 6 LSCS BREECH 2.7
Poongothai 26 I17032720 manager M.Phil 24.6 prom 38+4 4 106 22.8 5 NVD 2.88
Karthika 26 I17032759 HW 8th 29.7 abdominal pain 38 5 99 7.17 12 LSCS NPL 3
Kirubashini 25 I17033032 HW BBM 19.8 induced 40 4 97 8.84 5 NVD 2.9
Punitha Baby 28 I17033567 HW 12TH 27.2 abdominal pain 40 4 118 12.05 23 VACCUM 2.87
Hema 23 I17044735 HW 12TH 26.5 induced 40 5 102 16.36 12 NVD 3.28
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